Meng Zhishou, He Dongqin, Wang Honggang, Ma Lijuan, Guan Le, Ai Yongning, Yang Jianxin, Liu Ruxing
Department of Pain Management, Second Hospital of Shanxi Medical University, Taiyuan, 030001, People's Republic of China.
Department of Orthopedics, Second Hospital of Shanxi Medical University, Taiyuan, 030001, People's Republic of China.
J Multidiscip Healthc. 2025 Mar 4;18:1281-1295. doi: 10.2147/JMDH.S508807. eCollection 2025.
OBJECTIVE: The purpose of this study was to conduct a bibliometric analysis of the literature on stem cell therapy for osteoarthritis (OA) to visualize recent developments, identify hot spots, and determine trends in the field. BACKGROUND: OA is a chronic disease that affects the joints and their surrounding tissues, leading to progressive damage to the articular cartilage and ultimately to the subchondral bone and the surrounding synovial structures. OA is a disabling disease with an increasing incidence and prevalence in the general population. Modulation of immunity and inflammation and improvement of cell survival and differentiation through multidirectional differentiation of stem cells is a potential strategy for the treatment of OA. METHODS: We searched for publications on "stem cell therapy for osteoarthritis" in the Web of Science (WOS) core collection database from 1998-2024 and summarized the results, including year of publication, country, institution, author, and collaborative network generated using VOSviewer and Citespace. In addition, research trends were identified. Finally, we summarized the hot topics and identified future research trends. RESULTS: This study ultimately included 2341 valid papers, with a trend toward a gradual increase in the number of publications over time. The country, institution, author, and journal with the highest number of publications and citations were China, the University of California system, Sekiya I, and Osteoarthritis and Cartilage, respectively. High-frequency keyword clusters included cell therapy, stem cells, tissue engineering, and extracellular vesicles. CONCLUSION: Through visualization and analysis, we elucidated the trends and research hotspots in the field over the past five years. The analysis revealed that stem cell transplantation and exosome therapy for OA may be the focus of future research. This study lays the foundation for future research and clinical work on stem cell therapy in this field.
目的:本研究旨在对骨关节炎(OA)干细胞治疗的文献进行文献计量分析,以可视化近期进展、确定热点并明确该领域的趋势。 背景:OA是一种影响关节及其周围组织的慢性疾病,导致关节软骨进行性损伤,最终累及软骨下骨和周围的滑膜结构。OA是一种致残性疾病,在普通人群中的发病率和患病率呈上升趋势。通过干细胞的多向分化来调节免疫和炎症以及改善细胞存活和分化是治疗OA的一种潜在策略。 方法:我们在科学网(WOS)核心合集数据库中检索了1998年至2024年期间关于“骨关节炎干细胞治疗”的出版物,并总结了结果,包括发表年份、国家、机构、作者以及使用VOSviewer和Citespace生成的合作网络。此外,还确定了研究趋势。最后,我们总结了热点话题并确定了未来的研究趋势。 结果:本研究最终纳入2341篇有效论文,出版物数量随时间呈逐渐增加的趋势。发表论文和被引次数最多的国家、机构、作者和期刊分别是中国、加利福尼亚大学系统、关谷一和《骨关节炎与软骨》。高频关键词聚类包括细胞治疗、干细胞、组织工程和细胞外囊泡。 结论:通过可视化和分析,我们阐明了该领域过去五年的趋势和研究热点。分析表明,OA的干细胞移植和外泌体治疗可能是未来研究的重点。本研究为该领域干细胞治疗的未来研究和临床工作奠定了基础。
Front Cell Dev Biol. 2022-10-18
Front Physiol. 2022-12-22
Bioengineering (Basel). 2025-5-31
Stem Cell Res Ther. 2024-5-7
Biomedicines. 2024-3-27
Bioact Mater. 2023-12-8
Front Pharmacol. 2023-7-18